4
Participants
Start Date
July 31, 2000
Primary Completion Date
December 31, 2000
ISIS 2503
Beginning dosage of ISIS 2503 is 6 mg/kg/day given as a continuous i.v. infusion over the first 14 days of a 21-day treatment cycle. This will be repeated for the first two weeks of every three-week treatment cycle.
University of Alabama Comprehensive Cancer Center, Birmingham
Norris Cotton Cancer Center, Lebanon
Collaborators (1)
National Cancer Institute (NCI)
NIH
Ionis Pharmaceuticals, Inc.
INDUSTRY
University of Alabama at Birmingham
OTHER